1,375
Participants
Start Date
August 31, 1997
Study Completion Date
May 31, 2006
naltrexone (Revia)
acamprosate (Campral)
Treatment and Research Center, University of Pennsylvania, Philadelphia
Center for Alcohol Programs, Medical University of South Carolina, Charleston
University of Miami School of Medicine, Miami
University of Wisconsin-Milwaukee, Milwaukee
Southwest Texas Addiction Research and Technology Center, University of Texas Health Science Center, San Antonio
Center on Alcoholism, Substance Abuse and Addiction, University of New Mexico, Albuquerque
Addictions Treatment Center, University of Washington, Seattle
Substance Abuse Treatment Unit, Yale University, New Haven
Harvard University/McLean Hospital, Belmont
Massachusetts General Hospital, Boston
Boston University School of Medicine, Boston
Roger Williams Medical Center , Brown University, Providence
Collaborators (1)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
NIH
Lipha Pharmaceuticals
INDUSTRY
University of North Carolina, Chapel Hill
OTHER